Open AccessPirfenidone vs nintedanib for treatment of idiopathic pulmonary fibrosis in clinical practice: efficacy, tolerability, and adverse effects
Author(s) -
Amal Abd El-Azem Sadon,
Ahmed Saleh Kenawy,
Ashraf Abdelsalam,
Hosam Attia
Publication year - 2020
Publication title -
egyptian journal of chest diseases and tuberculosis/egyptian journal of chest diseases and tuberculosis
Language(s) - English
Resource type - Journals
eISSN - 2090-9950
pISSN - 0422-7638
DOI - 10.4103/ejcdt.ejcdt_140_19
Subject(s) - nintedanib , pirfenidone , medicine , tolerability , idiopathic pulmonary fibrosis , vital capacity , adverse effect , gastroenterology , diffusing capacity , lung , lung function